DKA vs HHS: Key Clinical Differences
Laboratory Distinctions
The most critical laboratory difference is that DKA presents with plasma glucose >250 mg/dL and significant ketoacidosis (pH <7.30), while HHS presents with markedly higher glucose ≥600 mg/dL, minimal ketones, and preserved pH ≥7.30. 1
Glucose and Osmolality
- DKA: Plasma glucose typically >250 mg/dL 1
- HHS: Plasma glucose ≥600 mg/dL, often much higher 1, 2
- HHS: Effective serum osmolality ≥320 mOsm/kg (calculated as 2[Na+ mEq/L] + glucose mg/dL/18), whereas DKA has variable osmolality 1, 2
Acid-Base Status
- DKA: Arterial pH ranges from <7.00 to 7.30, with serum bicarbonate <10 to 18 mEq/L 1
- HHS: Arterial pH >7.30, with serum bicarbonate >15 mEq/L 1, 2
- DKA: Elevated anion gap >10-12 mEq/L due to ketoacid accumulation 1
- HHS: Variable anion gap 1
Ketone Bodies
- DKA: Positive serum and urine ketones (ketonemia >3.0 mmol/L) 1, 2
- HHS: Small or absent ketones in serum and urine (ketonemia ≤3.0 mmol/L) 1, 2
Clinical Presentation Differences
Time Course
- DKA: Develops rapidly within 24 hours, or even 4-10 hours with insulin pump failure or complete insulin omission 1, 3
- HHS: Evolves slowly over several days to weeks 1, 2
Symptoms and Signs
Both conditions share polyuria, polydipsia, weight loss, and dehydration, but key differences include:
- DKA: Kussmaul respirations (deep, rapid breathing), abdominal pain and vomiting common, fruity breath odor 1
- HHS: More profound dehydration (total body water deficit ~9L vs ~6L in DKA), abdominal pain less common, no Kussmaul respirations 1
Mental Status
- DKA: Alert to stupor/coma 1
- HHS: Stupor/coma more frequent and correlates with degree of hyperosmolarity; altered consciousness is more common than in DKA 1, 2
Critical pitfall: Absence of altered mental status does not exclude HHS when metabolic criteria are met 2
Pathophysiology Differences
Both conditions involve insulin deficiency with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone), but the degree differs:
- DKA: Absolute or severe insulin deficiency leads to uncontrolled lipolysis, releasing free fatty acids that undergo hepatic β-oxidation to produce excess ketone bodies (acetoacetate, β-hydroxybutyrate, acetone), causing metabolic acidosis 1, 3, 4
- HHS: Residual insulin action is sufficient to prevent significant lipolysis and ketogenesis but inadequate to control hyperglycemia; this explains the minimal ketones despite severe hyperglycemia 1, 4
Patient Population Differences
- DKA: More common in younger patients with type 1 diabetes; approximately 25% of new type 1 diabetes diagnoses present as DKA 3, 5
- HHS: Predominantly affects adult and elderly patients with type 2 diabetes, especially those in long-term care facilities who cannot access adequate fluids 1, 5
Precipitating Factors
Common to Both
- Infection (most common precipitant, accounting for 30-50% of cases) 1, 3
- Cerebrovascular accident 1
- Myocardial infarction 1, 3
- Acute pancreatitis 1
- Medications: corticosteroids, thiazide diuretics, sympathomimetic agents 1, 3
DKA-Specific
- Insulin omission or inadequate dosing (most common in established type 1 diabetes, often related to psychosocial issues, financial barriers, or eating disorders) 3
- SGLT2 inhibitors (now a leading cause, including euglycemic DKA with glucose <200 mg/dL; relative risk 2.46-fold vs placebo) 3
- Insulin pump failure or disconnection 3
HHS-Specific
Management Differences
Fluid Resuscitation
Both conditions require initial isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr during the first hour, but HHS requires more aggressive total fluid replacement. 1
- DKA: Total body water deficit ~6L, sodium deficit ~100 mEq/kg, potassium deficit ~3-5 mEq/kg 1
- HHS: Total body water deficit ~9L (100-220 mL/kg), sodium deficit ~100-200 mEq/kg, potassium deficit ~5-15 mEq/kg; aim to correct deficits within 24 hours 1, 2
- HHS: Limit osmolality reduction to 3-8 mOsm/kg/hr to prevent cerebral edema and central pontine myelinolysis 2
Insulin Therapy
- DKA: Insulin is the cornerstone of therapy; start immediately with 0.1-0.15 units/kg IV bolus followed by 0.1 units/kg/hr infusion 2, 6
- HHS: Fluid replacement is the cornerstone of therapy; withhold insulin until glucose stops falling with IV fluids alone (unless ketonemia present), then start 0.15 units/kg bolus followed by 0.1 units/kg/hr 2
- DKA: Target glucose decline 50-75 mg/dL/hr; add dextrose when glucose reaches 150-200 mg/dL 2
- HHS: Target glucose decline 50-75 mg/dL/hr; add dextrose when glucose reaches 250-300 mg/dL and maintain at 200-250 mg/dL until resolution 2
Potassium Management
Both require aggressive potassium replacement, but HHS deficits are larger:
- If K+ <3.3 mEq/L: Hold insulin and give potassium until K+ ≥3.3 mEq/L 2
- Once renal function confirmed and K+ known: Add 20-30 mEq/L to IV fluids (2/3 KCl, 1/3 KPO₄) 1, 2
Bicarbonate Therapy
Mortality and Prognosis
- DKA: Mortality ~5% in experienced centers 1
- HHS: Mortality ~15%, significantly higher than DKA 1, 4
- Both: Prognosis worsened by extremes of age, coma, hypotension, and hypothermia 1
Critical pitfall: Hypothermia is a poor prognostic indicator and should prompt aggressive evaluation for infection, even though body temperature is unreliable for diagnosing infection in both conditions 1, 3
Mixed Presentations
Up to one-third of patients present with mixed features of both DKA and HHS. 6
- Mixed cases are managed using the same three-pronged approach: fluids, insulin, and electrolyte replacement 6
- Tailor therapy according to prominent clinical features 6
- In adults with mixed features, fluids may be administered more rapidly because cerebral edema risk is low 6
- In younger patients with mixed features, avoid rapid correction to minimize cerebral edema risk 6
Common Pitfalls to Avoid
- Failing to identify and treat the precipitating cause (especially infection) is the most common and dangerous pitfall in managing both conditions. 1, 2
- Do not rely on fever to diagnose infection; patients may be normothermic or hypothermic despite serious infection 1, 3
- Obtain appropriate cultures (blood, urine, throat) and initiate empiric antibiotics when infection is suspected 1, 2
- In DKA, abdominal pain may be either cause or consequence; if pain persists after standard therapy, evaluate for intra-abdominal pathology 1
- Never discontinue basal insulin, even when patient is not eating, as this can precipitate DKA within 4-10 hours 3
- In HHS, do not add dextrose too early, as this delays correction of hyperosmolarity and prolongs altered mental status 2